<DOC>
	<DOCNO>NCT02240641</DOCNO>
	<brief_summary>The study aim compare evolution renal function patient show hypertension treat various therapeutic strategy . Due contract research organisation ( CRO ) decision September 2000 , database lock accessible Boehringer Ingelheim France . Consequently decide stop study proceed analysis . Thus , safety data process safety database .</brief_summary>
	<brief_title>Effect CaldineÂ® Renal Function Balanced Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Lacidipine</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Enzyme Inhibitors</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<mesh_term>Adrenergic alpha-Antagonists</mesh_term>
	<criteria>patient hypertension require treatment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>